Earth Science Tech, Inc. (OTC: ETST) announced financial and operational results for the third fiscal quarter ended December 31, 2025, showcasing significant year-over-year growth. The company reported revenue of $8.4 million, a 14.1% increase compared to the prior-year period. Gross profit reached $6.4 million, reflecting a robust 76.3% margin, while net income surged 341% to $910,000. Adjusted EBITDA totaled $1.2 million, underscoring improved operational efficiency.
Total assets increased to $8.1 million, and the company ended the quarter with $416,000 in cash, $773,000 in working capital, and no bank debt. During the first nine months of fiscal 2026, Earth Science Tech repurchased and retired 3.7 million shares, demonstrating a commitment to shareholder value. Management attributed the strong performance to continued operating leverage and expansion initiatives heading into calendar 2026.
Earth Science Tech operates as a strategic holding company focused on value creation through acquisitions and operational optimization. Its subsidiaries include RxCompoundStore.com, Peaks Curative, Avenvi, Mister Meds, Earth Science Foundation, Las Villas Health Care, DOConsultations, and an 80% interest in MagneChef. The company’s operations span compounding pharmaceuticals, telemedicine, and real estate development.
The results were featured in a press release available at https://ibn.fm/emIBm. For more updates on ETST, visit the company's newsroom at https://ibn.fm/ETST.
The announcement underscores Earth Science Tech's ability to drive profitability while expanding its business lines, positioning the company for sustained growth in the coming quarters.
